Literature DB >> 31398601

New classes of carbazoles as potential multi-functional anti-Alzheimer's agents.

Niloufar Choubdar1, Mostafa Golshani2, Leili Jalili-Baleh2, Hamid Nadri3, Tuba Tüylü Küçükkilinç4, Beyza Ayazgök4, Alireza Moradi3, Farshad Homayouni Moghadam5, Zahra Abdolahi3, Alieh Ameri6, Fatemeh Salehian2, Alireza Foroumadi2, Mehdi Khoobi7.   

Abstract

Multi-Target approach is particularly promising way to drug discovery against Alzheimer's disease. In the present study, we synthesized a series of compounds comprising the carbazole backbone linked to the benzyl piperazine, benzyl piperidine, pyridine, quinoline, or isoquinoline moiety through an aliphatic linker and evaluated as cholinesterase inhibitors. The synthesized compounds showed IC50 values of 0.11-36.5 µM and 0.02-98.6 µM against acetyl- and butyrylcholinesterase (AChE and BuChE), respectively. The ligand-protein docking simulations and kinetic studies revealed that compound 3s could bind effectively to the peripheral anionic binding site (PAS) and anionic site of the enzyme with mixed-type inhibition. Compound 3s was the most potent compound against AChE and BuChE and showed acceptable inhibition potency for self- and AChE-induced Aβ1-42 aggregation. Moreover, compound 3s could significantly protect PC12 cells against H2O2-induced toxicity. The results suggested that the compounds 3s could be considered as a promising multi-functional agent for further drug discovery development against Alzheimer's disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Carbazoles; Docking study; β-amyloid aggregation

Mesh:

Substances:

Year:  2019        PMID: 31398601     DOI: 10.1016/j.bioorg.2019.103164

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

Review 1.  Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.

Authors:  Giambattista Marotta; Filippo Basagni; Michela Rosini; Anna Minarini
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

2.  Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-d-Aspartate Receptor Antagonists.

Authors:  Jan Konecny; Anna Misiachna; Martina Hrabinova; Lenka Pulkrabkova; Marketa Benkova; Lukas Prchal; Tomas Kucera; Tereza Kobrlova; Vladimir Finger; Marharyta Kolcheva; Stepan Kortus; Daniel Jun; Marian Valko; Martin Horak; Ondrej Soukup; Jan Korabecny
Journal:  Biomolecules       Date:  2020-12-22

3.  Novel Coumarin-Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer's Disease.

Authors:  Elaheh Babaei; Tuba Tüylü Küçükkılınç; Leili Jalili-Baleh; Hamid Nadri; Esin Öz; Hamid Forootanfar; Elaheh Hosseinzadeh; Tayebeh Akbari; Mehdi Shafiee Ardestani; Loghman Firoozpour; Alireza Foroumadi; Mohammad Sharifzadeh; Bi Bi Fatemeh Mirjalili; Mehdi Khoobi
Journal:  Front Chem       Date:  2022-06-30       Impact factor: 5.545

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.